Gaudium IVF Share Price Highlights: Stock ends at ₹80.40 apiece on NSE, 1.77% premium to IPO price

Gaudium IVF Share Price Highlights: Gaudium IVF share price ended listing day at ₹80.40 on NSE, a 1.77% premium to the IPO price of ₹79, and at ₹80.48 on BSE, a 1.87% premium.

Gaudium IVF Share Price LIVE: According to Darshan Rathod, COO, MULTYFI, Gaudium IVF operates in a growing healthcare segment. The IVF industry in India is expanding because more couples are seeking fertility treatments due to lifestyle changes and delayed parenthood. So the overall business opportunity is strong.

After listing, the stock price may see some volatility. This is normal for newly listed stocks, especially when trading volumes are limited. Early price movements are often driven by short-term traders rather than long-term investors.

"What really matters now is how the company performs over the next few quarters. Investors should watch revenue growth, clinic expansion, margins, and how efficiently the company manages its costs.

If the company continues to grow steadily and maintains healthy profitability, the stock can gain stability and investor confidence. But if growth slows or margins come under pressure, the share price may remain volatile.

So instead of focusing only on listing gains, investors should focus on business performance and long-term execution," said Rathod.

Gaudium IVF Share Price LIVE: The Indian IVF industry stands at the intersection of demographic demand, technological innovation, regulatory formalization, and evolving business models. With favourable population dynamics and improving affordability, India is positioned to emerge as a high-growth hub within the global IVF landscape, offering long-term opportunities for organized operators.

Gaudium IVF Share Price LIVE: Investment Rationale

1. Patient-centric fertility care backed by clinical expertise and advanced reproductive technology
2. Asset-light hub-and-spoke model driving scalable growth and standardized clinical excellence

Gaudium IVF Share Price LIVE: These are two key services;

1. Specialized fertility services are offered by the company, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. Treatments are designed to address various infertility challenges in both genders. Comprehensive gynecological care is provided for PCOD/PCOS and endometriosis, along with high-risk pregnancy management for women with complex fertility histories or health conditions. A full spectrum of male infertility treatments is also made available, including advanced sperm retrieval techniques.
2. The company has centers in major cities: two in Delhi (Janakpuri, Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.

Gaudium IVF Share Price LIVE: The net proceeds from the fresh issue will be used towards the following purposes:

1. Funding capital expenditure towards establishment of new IVF Centers of the company ;
2. Repayment/pre-payment, in full or in part, of certain outstanding loans availed by thecompany; and
3. General corporate purposes.

Gaudium IVF Share Price LIVE: Check out key risks

1. The company operates in the fertility healthcare segment and is exposed to operational, medical, legal, and reputational risks inherent in providing treatments such as IVF, IUI, ICSI, and egg freezing. Any adverse clinical outcomes, procedural complications, regulatory non-compliance, or failure to maintain consistent treatment quality could negatively impact patient trust, brand reputation, and future patient inflows, thereby materially affecting the company’s business performance and financial results.
2. The company operations are highly dependent on the availability and retention of qualified doctors, nurses, embryologists, and other healthcare professionals. The company has experienced elevated employee attrition, which may affect service continuity and clinical consistency.

Gaudium IVF Share Price LIVE: Stock slips into red after decent listing, down over 3% on BSE and NSE.

Gaudium IVF Share Price LIVE: Gaudium IVF share price made a positive debut on the bourses today. On NSE and BSE, Gaudium IVF share price opened at ₹83 per share, 5.06% higher than the issue price of ₹79.

Gaudium IVF Share Price LIVE: The planned offering consists of a new issue of 1.14 crore equity shares and a sale of approximately 95 lakh equity shares by promoter Manika Khanna.

The funds raised from the new issue will be used to set up 19 new IVF centres throughout India, as well as to pay off debt and for general corporate needs.

Gaudium IVF Share Price LIVE: Gaudium IVF and Women Health, a provider of fertility services, witnessed a subscription rate of 7.27 times for its initial public offering (IPO) on the last day of the share sale on Tuesday.

The company's IPO, valued at ₹165 crores, received bids for 10,63,50,489 shares, whereas only 1,46,20,340 shares were available, as per the data from the NSE.

The quota for Non-Institutional Investors was subscribed 14.05 times, while the segment for retail individual investors was subscribed 7.60 times. Additionally, the portion allocated to qualified institutional buyers saw a subscription rate of 1.62 times.

Gaudium IVF Share Price LIVE: Gaudium IVF and Women Health shares will be in the Trade-for-Trade segment for 10 trading days.

Further the trading members may please note that the above-mentioned scrip will be a part of Special Pre-open Session (SPOS) on Friday, February 27, 2026, it added, and the stock will be available for trading from 10:00 AM.

Gaudium IVF Share Price LIVE: Gaudium IVF IPO GMP today was ₹0, which meant shares were trading at their issue price of ₹79 with no premium or discount in the grey market, according to investorgain.com.

Based on the grey market activities from the last 15 sessions, the current GMP ( ₹0) indicates a downward trend. The minimum GMP recorded is ₹-4.00, whereas the maximum GMP reached is ₹15, as per expert analysis.

'Grey market premium' indicates investors' readiness to pay more than the issue price.

Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.